Enhabit is in a disastrous financial situation, with management itself warning of substantial doubt about continuing as a going concern. It has $36M of pro forma liquidity while burning more than $20M a quarter, under six months of runway. That sets up a negative loop: a lower market cap makes raising capital harder, lowering confidence and the market cap further, which explains the downward spiral. The likely path is an inevitable capital raise. x.com 

Aspen Aerogels could return to the $20-30 area as European auto contracts ramp and reduce its dependence on GM. Its PyroThin barrier stops a failing EV battery cell from becoming a pack fire, and new wins include Toyota, ACC/Mercedes, Volvo, JLR, Audi, Scania and an unnamed US OEM, mostly entering production in 2027 and later. These could reach 50%+ of PyroThin revenue, versus about 50% from GM. Proprietary processes and 400 patents form a moat, and the depressed price gives good risk-reward. … Show more

Aspen Aerogels looks cheap at $6.89, about 20% below the low end of an estimated $8.58-10.92 fair-value range. The levels come only from reported earnings and revenue estimates, not fundamental work; the stock trades at 1.6x EV/sales with negative forward EPS, and $5.36 is the pullback zone. x.com